STOCK TITAN

Neuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Neuraxis, INC Chief Financial Officer buys company stock in open market trade. On April 1, 2026, CFO Timothy Robert Henrichs purchased 7,593 shares of Neuraxis common stock in an open-market transaction at a price of $1.96 per share. Following this purchase, he directly owns 7,593 shares.

Positive

  • None.

Negative

  • None.
Insider Henrichs Timothy Robert
Role Chief Financial Officer
Bought 7,593 shs ($15K)
Type Security Shares Price Value
Purchase Common Stock 7,593 $1.96 $15K
Holdings After Transaction: Common Stock — 7,593 shares (Direct)
Footnotes (1)
Shares purchased 7,593 shares Open-market purchase on April 1, 2026
Purchase price $1.96 per share Common Stock transaction
Total shares after transaction 7,593 shares CFO direct ownership following purchase
Net buy shares 7,593 shares Net buy direction in transaction summary
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Henrichs Timothy Robert

(Last)(First)(Middle)
11611 N. MERIDIAN ST, SUITE 330

(Street)
CARMEL INDIANA 46032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026P7,593A$1.967,593D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Timothy Henrichs04/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Neuraxis (NRXS) report in this Form 4?

Neuraxis reported that its Chief Financial Officer, Timothy Robert Henrichs, made an open-market purchase of common stock. He bought 7,593 shares on April 1, 2026, at a price of $1.96 per share, increasing his direct ownership to 7,593 shares.

How many Neuraxis (NRXS) shares did the CFO buy and at what price?

The CFO purchased 7,593 shares of Neuraxis common stock at $1.96 per share. This was an open-market transaction dated April 1, 2026, and the filing shows these 7,593 shares as his total direct holdings after the trade.

What is the CFO’s total Neuraxis (NRXS) shareholding after this transaction?

After the reported trade, the CFO directly owns 7,593 Neuraxis common shares. The Form 4 shows the total shares following the transaction equal to 7,593, indicating this open-market purchase established or matched his direct ownership position at that level.

Was the Neuraxis (NRXS) CFO’s trade a buy or a sell?

The transaction was a buy. The Form 4 classifies it as an open-market purchase, coded “P,” with a transaction direction of “buy.” The CFO acquired 7,593 shares of common stock at a price of $1.96 per share on April 1, 2026.

Is the Neuraxis (NRXS) CFO’s ownership direct or through another entity?

The filing shows the CFO’s ownership as direct. The transaction is marked with ownership code “D” and ownership type “direct,” with no nature-of-ownership footnote describing any trust, partnership, or other indirect holding structure for the 7,593 shares.